Basil Theofanopoulos

His more than 20 years of experience in the pharmaceutical industry in several leadership and management positions and his extensive scientific, regulatory, business development and technical expertise in the fields of pharmacology, pharmaceutics and pharmacokinetics, are invaluable company assets. As the head of Research & Development, he oversees the division’s Pharmaceutics, Product Development, Technical Services and Regulatory Affairs departments, and he also participates in Sigmapharm's Unique Product Selection process. Basil has been an old academic collaborator of Dr. Spireas during and after their tenure as graduate students and doctoral candidates at St. John’s University, when they worked together and published several scientific articles and abstracts in the fields of pharmaceutical and analytical development. Prior to joining Sigmapharm in 2014, Dr. Theofanopoulos was the Managing Director of Gerolymatos, Inc., where he established and managed that company’s U.S. pharmaceutical activities, while previously also holding positions in that company as Scientific Advisor and Director of Pharmaceutical Business Development. Basil holds a Ph.D. degree in Pharmacology and a B.S. degree in Pharmacy, both from St. John’s University, Jamaica, New York.